459 related articles for article (PubMed ID: 17919258)
21. Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke.
Tiwari P; Khan H; Singh TG; Grewal AK
Neurochem Res; 2022 Jul; 47(7):1830-1852. PubMed ID: 35437712
[TBL] [Abstract][Full Text] [Related]
22. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors.
Jagtap P; Szabó C
Nat Rev Drug Discov; 2005 May; 4(5):421-40. PubMed ID: 15864271
[TBL] [Abstract][Full Text] [Related]
23. Natural inhibitors of poly(ADP-ribose) polymerase-1.
Banasik M; Stedeford T; Strosznajder RP
Mol Neurobiol; 2012 Aug; 46(1):55-63. PubMed ID: 22476980
[TBL] [Abstract][Full Text] [Related]
24. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury.
Szabó G; Bährle S
Curr Vasc Pharmacol; 2005 Jul; 3(3):215-20. PubMed ID: 16026318
[TBL] [Abstract][Full Text] [Related]
25. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
Oh KS; Lee S; Yi KY; Seo HW; Koo HN; Lee BH
J Pharmacol Exp Ther; 2009 Jan; 328(1):10-8. PubMed ID: 18836068
[TBL] [Abstract][Full Text] [Related]
26. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
[TBL] [Abstract][Full Text] [Related]
27. Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease.
Kauppinen TM
Neurochem Int; 2007 Jun; 50(7-8):954-8. PubMed ID: 17222947
[TBL] [Abstract][Full Text] [Related]
28. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
29. Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts.
Zhou HZ; Swanson RA; Simonis U; Ma X; Cecchini G; Gray MO
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H714-23. PubMed ID: 16582021
[TBL] [Abstract][Full Text] [Related]
30. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.
Szabó C; Dawson VL
Trends Pharmacol Sci; 1998 Jul; 19(7):287-98. PubMed ID: 9703762
[TBL] [Abstract][Full Text] [Related]
31. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.
Pacher P; Szabó C
Antioxid Redox Signal; 2005; 7(11-12):1568-80. PubMed ID: 16356120
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.
Kaplan J; O'Connor M; Hake PW; Zingarelli B
Shock; 2005 Mar; 23(3):233-8. PubMed ID: 15718920
[TBL] [Abstract][Full Text] [Related]
33. BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase.
Szabados E; Literati-Nagy P; Farkas B; Sumegi B
Biochem Pharmacol; 2000 Apr; 59(8):937-45. PubMed ID: 10692558
[TBL] [Abstract][Full Text] [Related]
34. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation.
Soriano FG; Virág L; Szabó C
J Mol Med (Berl); 2001 Aug; 79(8):437-48. PubMed ID: 11511974
[TBL] [Abstract][Full Text] [Related]
35. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.
Luo X; Kraus WL
Genes Dev; 2012 Mar; 26(5):417-32. PubMed ID: 22391446
[TBL] [Abstract][Full Text] [Related]
36. Targeting poly(ADP-ribose) polymerase activity for cancer therapy.
Mégnin-Chanet F; Bollet MA; Hall J
Cell Mol Life Sci; 2010 Nov; 67(21):3649-62. PubMed ID: 20725763
[TBL] [Abstract][Full Text] [Related]
37. Modulating poly (ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress.
Decker P; Muller S
Curr Pharm Biotechnol; 2002 Sep; 3(3):275-83. PubMed ID: 12164482
[TBL] [Abstract][Full Text] [Related]
38. Poly(ADP-ribose)polymerase inhibition - where now?
Woon EC; Threadgill MD
Curr Med Chem; 2005; 12(20):2373-92. PubMed ID: 16181138
[TBL] [Abstract][Full Text] [Related]
39. Poly(ADP-ribose) polymerase-1: a novel therapeutic target in necrotizing enterocolitis.
Giannone PJ; Alcamo AA; Schanbacher BL; Nankervis CA; Besner GE; Bauer JA
Pediatr Res; 2011 Jul; 70(1):67-71. PubMed ID: 21399558
[TBL] [Abstract][Full Text] [Related]
40. Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure.
Devalaraja-Narashimha K; Singaravelu K; Padanilam BJ
Pharmacol Res; 2005 Jul; 52(1):44-59. PubMed ID: 15911333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
